Winnergy Medical Public Company Limited(TH:WINMED)
฿1.230.00 (0.00%)
TH:WINMED
Winnergy Medical Public Company Limited financials statements
฿1.23
At close:0.00 (0.00%)
Winnergy Medical Public Company Limited (WINMED) Ratios
Winnergy Medical Public Company Limited Ratios
TH:WINMED's free cash flow for Q2 2026 was ฿27.96M. For the 2026 fiscal year, TH:WINMED's free cash flow was decreased by ฿-12.45M and operating cash flow was ฿40.41M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.75 | 1.83 | 1.88 | 2.80 | 3.23 |
| Quick Ratio | 1.17 | 1.44 | 1.44 | 2.35 | 2.62 |
| Cash Ratio | 0.06 | 0.08 | 0.13 | 0.41 | 0.98 |
| Solvency Ratio | 0.13 | 0.17 | 0.20 | 0.40 | 0.54 |
| Operating Cash Flow Ratio | -0.07 | 0.37 | 0.14 | -0.43 | 0.70 |
| Short-Term Operating Cash Flow Coverage | -0.11 | 0.76 | 0.22 | -0.72 | 3.95 |
| Net Current Asset Value | ฿ 86.60M | ฿ 76.96M | ฿ 145.01M | ฿ 232.62M | ฿ 233.32M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.28 | 0.26 | 0.20 | 0.08 |
| Debt-to-Equity Ratio | 0.57 | 0.49 | 0.42 | 0.29 | 0.11 |
| Debt-to-Capital Ratio | 0.36 | 0.33 | 0.30 | 0.22 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.14 | 0.16 | 0.02 | 0.04 | 0.00 |
| Financial Leverage Ratio | 1.79 | 1.75 | 1.62 | 1.43 | 1.32 |
| Debt Service Coverage Ratio | 0.24 | 0.58 | 0.48 | 0.98 | 3.71 |
| Interest Coverage Ratio | 0.53 | 2.01 | 3.76 | 8.76 | 11.77 |
| Debt to Market Cap | 0.81 | 0.36 | 0.15 | 0.08 | 0.01 |
| Interest Debt Per Share | 0.95 | 0.80 | 0.66 | 0.45 | 0.19 |
| Net Debt to EBITDA | 5.63 | 2.96 | 2.48 | 0.85 | -0.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 42.70% | 41.00% | 40.90% | 37.23% | 45.17% |
| EBIT Margin | 1.30% | 7.05% | 6.93% | 10.86% | 14.31% |
| EBITDA Margin | 9.43% | 14.70% | 13.95% | 16.66% | 20.56% |
| Operating Profit Margin | 1.30% | 3.74% | 5.33% | 8.56% | 10.79% |
| Pretax Profit Margin | 2.95% | 5.19% | 5.52% | 9.88% | 13.40% |
| Net Profit Margin | 2.34% | 4.47% | 4.79% | 8.63% | 12.10% |
| Continuous Operations Profit Margin | 2.34% | 4.47% | 4.79% | 8.63% | 12.10% |
| Net Income Per EBT | 79.55% | 86.12% | 86.91% | 87.27% | 90.36% |
| EBT Per EBIT | 227.10% | 138.84% | 103.42% | 115.40% | 124.16% |
| Return on Assets (ROA) | 1.33% | 2.65% | 3.13% | 7.15% | 8.63% |
| Return on Equity (ROE) | 2.39% | 4.63% | 5.07% | 10.20% | 11.40% |
| Return on Capital Employed (ROCE) | 1.05% | 3.04% | 4.86% | 8.93% | 9.28% |
| Return on Invested Capital (ROIC) | 0.65% | 2.21% | 3.40% | 6.72% | 8.05% |
| Return on Tangible Assets | 1.38% | 2.74% | 3.21% | 7.31% | 8.79% |
| Earnings Yield | 3.83% | 4.04% | 2.55% | 3.56% | 3.08% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.85 | 1.65 | 1.81 | 2.26 | 2.66 |
| Payables Turnover | 6.14 | 4.31 | 5.46 | 18.27 | 4.17 |
| Inventory Turnover | 1.89 | 3.31 | 3.15 | 5.67 | 3.74 |
| Fixed Asset Turnover | 1.52 | 1.51 | 1.83 | 2.48 | 2.07 |
| Asset Turnover | 0.57 | 0.59 | 0.65 | 0.83 | 0.71 |
| Working Capital Turnover Ratio | 2.57 | 2.66 | 2.30 | 2.34 | 3.51 |
| Cash Conversion Cycle | 331.23 | 246.70 | 250.43 | 206.12 | 147.27 |
| Days of Sales Outstanding | 197.30 | 221.10 | 201.57 | 161.71 | 137.32 |
| Days of Inventory Outstanding | 193.34 | 110.36 | 115.74 | 64.39 | 97.49 |
| Days of Payables Outstanding | 59.40 | 84.76 | 66.88 | 19.98 | 87.54 |
| Operating Cycle | 390.63 | 331.46 | 317.31 | 226.10 | 234.81 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.06 | 0.28 | 0.09 | -0.19 | 0.25 |
| Free Cash Flow Per Share | -0.15 | -0.21 | -0.15 | -0.35 | -0.12 |
| Dividend Paid and CapEx Coverage Ratio | -0.58 | 0.54 | 0.32 | -0.81 | 0.52 |
| Capital Expenditure Coverage Ratio | -0.75 | 0.57 | 0.40 | -1.13 | 0.68 |
| Operating Cash Flow Coverage Ratio | -0.07 | 0.36 | 0.15 | -0.44 | 1.43 |
| Operating Cash Flow to Sales Ratio | -0.04 | 0.17 | 0.06 | -0.11 | 0.17 |
| Free Cash Flow Yield | -14.68% | -11.57% | -5.08% | -8.25% | -2.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 26.12 | 24.76 | 39.16 | 28.40 | 32.78 |
| Price-to-Sales (P/S) Ratio | 0.61 | 1.11 | 1.88 | 2.42 | 3.93 |
| Price-to-Book (P/B) Ratio | 0.62 | 1.15 | 1.99 | 2.86 | 3.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.81 | -8.64 | -19.67 | -12.12 | -48.92 |
| Price-to-Operating Cash Flow Ratio | -15.90 | 6.51 | 32.02 | -22.87 | 23.31 |
| Price-to-Earnings Growth (PEG) Ratio | -0.54 | -5.42 | -0.80 | -1.70 | 0.85 |
| Enterprise Value Multiple | 12.12 | 10.48 | 15.94 | 15.39 | 18.54 |
| Enterprise Value | 739.36M | 1.01B | 1.42B | 1.80B | 2.05B |
| EV to EBITDA | 12.12 | 10.48 | 15.94 | 15.39 | 18.54 |
| EV to Sales | 1.14 | 1.54 | 2.22 | 2.56 | 3.81 |
| EV to Free Cash Flow | -12.72 | -12.04 | -23.30 | -12.83 | -47.47 |
| EV to Operating Cash Flow | -29.69 | 9.08 | 37.93 | -24.20 | 22.61 |
| Tangible Book Value Per Share | 1.49 | 1.49 | 1.45 | 1.44 | 1.56 |
| Shareholders’ Equity Per Share | 1.59 | 1.58 | 1.51 | 1.49 | 1.60 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.14 | 0.13 | 0.13 | 0.10 |
| Revenue Per Share | 1.62 | 1.64 | 1.60 | 1.76 | 1.50 |
| Net Income Per Share | 0.04 | 0.07 | 0.08 | 0.15 | 0.18 |
| Tax Burden | 0.80 | 0.86 | 0.87 | 0.87 | 0.90 |
| Interest Burden | 2.27 | 0.74 | 0.80 | 0.91 | 0.94 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.41 | 0.37 | 0.36 | 0.29 | 0.35 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.64 | 3.80 | 1.22 | -1.23 | 1.39 |
Currency in THB
